Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 13/20 | 0.41 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19152845 | 0.87 | HSP90AA1 (0.40) | ALDH1A1PDK2CYP2C9CYP2C19PTPN1 | |
| SCHEMBL19152735 | 0.84 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL19152742 | 0.81 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL19152594 | 0.79 | CNR1 (0.37) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL19153357 | 0.77 | NPSR1 (0.51) | SMN1; SMN2ALDH1A1POLBPDK2 | |
| SCHEMBL16020419 | 0.76 | CA2 (0.57) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL17500171 | 0.76 | CA2 (0.59) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL31027271 | 0.76 | CA2 (0.59) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL17500091 | 0.75 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL30595509 | 0.75 | PDK2 (0.46) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170204129-A1 | NOVEL TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION FOR POLYMERIZING OLEFIN, CONTAINING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2017-07-20 | — | — | US | disclosed |
| US-8232359-B2 | Process for preparing ethylene homopolymers or copolymers of ethylene with α-olefin by using the transition metal compound | SK INNOVATION CO., LTD. (KR) | 2012-07-31 | — | — | US | disclosed |
| US-20110319576-A1 | PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE WITH ALPHA-OLEFIN BY USING THE TRANSITION METAL COMPOUND | SK ENERGY CO., LTD. (KR) | 2011-12-29 | — | — | US | disclosed |
| EP-2326654-A2 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND - OLEFINS USING THE SAME. | SK Energy Co., Ltd. (KR) | 2011-06-01 | — | — | EP | disclosed |
| US-20110098426-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF THE ETHYLENE AND a-OLEFINS USING THE SAME | SK ENERGY CO., LTD. (KR) | 2011-04-28 | — | — | US | disclosed |
| US-7928173-B2 | Transition metal catalytic systems and methods for preparing ethylene homopolymers or copolymers of ethylene and α-olefins using the same | SK ENERGY CO., LTD. (KR) | 2011-04-19 | — | — | US | disclosed |
| US-20100081776-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND a-OLEFINS USING THE SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2010-04-01 | — | — | US | disclosed |
| WO-2010036025-A2 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND α- OLEFINS USING THE SAME. | SK ENERGY CO., LTD. (KR) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081776-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND a-OLEFINS USING THE SAME | ESR1, AOC3, PPOX | SMN1; SMN2 1853/4885ALDH1A1 1685/4885CA2 1460/4885 |
| US-20110098426-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF THE ETHYLENE AND a-OLEFINS USING THE SAME | ESR1, AOC3, AOC2 | SMN1; SMN2 1999/4885ALDH1A1 1883/4885CA2 1401/4885 |
| US-20170204129-A1 | NOVEL TRANSITION METAL COMPOUND, TRANSITION METAL CATALYST COMPOSITION FOR POLYMERIZING OLEFIN, CONTAINING SAME, AND METHOD FOR PREPARING ETHYLENE HOMOPOLYMER OR COPOLYMER OF ETHYLENE AND ALPHA-OLEFIN BY USING SAME | ETFA, ETFB, EMC2 | SMN1; SMN2 2899/4885ALDH1A1 2989/4885CA2 2956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.